Lepu Biopharma Cancer Drug's NDA Approved by China's NDMA; Stocks Up 8%
Lepu Biopharma Cancer Drug's NDA Approved by China's NDMA; Stocks Up 8%
乐普生物癌症药物的新药申请获得中国国药监局批准；股票上涨8%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间